TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03685773

The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients

Cause of deathStaffing, sites or logistics, also regulatory or ethics Automatic label, confidence 0.5, unverified. How labels are made.
“Permanently terminated due to COVID-19 given the poor vaccine penetrance in liver transplant recipients. This is not a suspension of IRB approval.”

The sponsor’s own words in the registry.

Life of this trial

2018201920202021202220232024Registered2018-09-24Planned start2019-04-21 (planned)Withdrawn (as of)2023-06-05

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
Albert Einstein College of Medicine
Sponsor type
University, hospital or other
Conditions
Diabetes Mellitus, Type 2; Glucose, High Blood; Glucose Metabolism Disorders
Interventions
Diazoxide; Placebo (for diazoxide); Nicotinic acid
Participants
0
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.